Health Laws And Places

Philippine Health Laws and Places on Focus

Home » Posts tagged 'biopharmaceutical sector'

Tag Archives: biopharmaceutical sector

Latest Posts

HL & P Accredited Travel Agents
Officially accredited by HL & P Website, this DTI registered Highlands Travel Consultancy under Certificate Number no. 04658454 with Office Address at 92 Bansalangin St.,…
How to protect yourself from COVID-19, if you are a frontliner?
The most perplexing but sad part of COVID-19 Pandemic is, aside from patients, doctors are also dying due to the virus. Sometimes, they die ahead…
What to do next, if COVID-19 positive is refused isolation?
If the hospital or the Local Chief Executive refuses to isolate you, being COVID-19 positive, in a health facility because of lack of space or…
Steam Inhalation Therapy: Answer to COVID-19 Pandemic
COVID-19 Pandemic brings to fore various behavioral reactions of different sectors of the society, worldwide, and it seems that everybody was caught by total surprise.…
Is salary increase for devolved PHWs possible despite the PS limitation?
In case, the Local Government Unit (LGU) is about to exceed the budgetary Personal Services (PS) Limitation, is there an alternative remedy for devolved public…
Are LGU Hospitals and RHUs exempt from PS limitation?
A major issue in devolved health facilities, e.g, devolved hospitals and Rural Health Units (RHUs), concerns the personal services (PS) limitation being applied to them…
PPHA Magna Carta Benefits Petition Partly Granted
In G.R. No. 207145, the Supreme Court (SC) en banc ruled on the petition on Magna Carta benefits filed by the Philippine Public Health Association,…

Business Ethics in Biopharmaceutical Sector

October 22, 2013 1:27 pm

Students on the watch

The Mexico City “voluntary codes of business ethics” was recently adopted by Food and Drugs Administration. Under FDA Circular no. 2013-024, dated September 5, 2013, ethical violations are grounds for filing appropriate administrative charges and/or imposition of administrative sanctions such as, but not limited to, imposition of fines, suspension, cancellation or revocation of any license, permit or registration issued by FDA.

The circular was issued as a result of the 17th APEC Small and Medium Enterprise (SME) Ministerial Meeting, where the “The Mexico City Principles” was endorsed. The principles aim to:

Significantly reduce ethics compliance costs for SMEs by (more…)

Create a free website or blog at WordPress.com.

Tag Archives: biopharmaceutical sector

Latest Posts

Follow Blog via Email